Literature DB >> 24097378

The control of oocyte survival by intrinsic and extrinsic factors.

Meltem Kurus1, Cengiz Karakaya, Mete Hakan Karalok, Grace To, Joshua Johnson.   

Abstract

CAPSULE: Mechanisms that control the survival of oocytes and, by extension, the duration of ovarian function have been identified. However, it is still not clear whether oocyte "quality" is related to survival, nor is the role of the granulosa cells of follicles in follicle survival entirely understood. Here, we consider oocyte-intrinsic and oocyte-extrinsic mechanisms of oocyte loss and argue that developing a better understanding of such physiological events is needed to protect fertility, fecundity, and ovarian function in women.The duration that ovaries function is, as is intuitive, controlled by the number of remaining oocytes within follicles. Once the number of follicles drops beneath a threshold number, ovarian function ceases. Thus, understanding mechanisms that control oocyte survival is paramount as we consider strategies to protect or prolong ovarian function in women. It is often assumed that physiological oocyte survival is entirely controlled by "oocyte- intrinsic" factors, such as poor genetic quality or accumulated damage to the oocyte itself. Oocytes that have poor genetic quality due to development or accumulated damage would then die sooner than those of higher "quality." Indeed, new data suggest that oocyte-intrinsic genetic quality as determined by the ability to repair double-stranded DNA breaks is a significant contributor to oocyte survival and the duration of ovarian function. However, the nature of the follicle, where the oocyte and surrounding granulosa cells exist in intimate contact and rely upon each other for survival signals and metabolic function, makes it unlikely that oocyte-intrinsic factors entirely control oocyte survival. We and others are assessing the role of adjacent somatic (granulosa) cells in follicle survival, determining the relative importance of "oocyte-extrinsic" factors.

Entities:  

Mesh:

Year:  2013        PMID: 24097378     DOI: 10.1007/978-1-4614-8214-7_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Reduced serum levels of anti-Müllerian hormone in females with inherited bone marrow failure syndromes.

Authors:  Martha M Sklavos; Pamela Stratton; Neelam Giri; Blanche P Alter; Sharon A Savage; Ligia A Pinto
Journal:  J Clin Endocrinol Metab       Date:  2014-11-18       Impact factor: 5.958

Review 2.  Metabolic control of oocyte development: linking maternal nutrition and reproductive outcomes.

Authors:  Ling Gu; Honglin Liu; Xi Gu; Christina Boots; Kelle H Moley; Qiang Wang
Journal:  Cell Mol Life Sci       Date:  2014-10-04       Impact factor: 9.261

3.  Myoinositol Improves Embryo Development in PCOS Patients Undergoing ICSI.

Authors:  Artur Wdowiak
Journal:  Int J Endocrinol       Date:  2016-09-29       Impact factor: 3.257

4.  The effect of different vitrification protocols on cell survival in human ovarian tissue: a pilot study.

Authors:  J Marschalek; C Egarter; K Nouri; S Dekan; J Ott; M Frank; D Pietrowski
Journal:  J Ovarian Res       Date:  2021-12-06       Impact factor: 4.234

5.  The antiandrogenic vinclozolin induces differentiation delay of germ cells and changes in energy metabolism in 3D cultures of fetal ovaries.

Authors:  Silvia González-Sanz; Odei Barreñada; Eduardo Rial; Miguel A Brieño-Enriquez; Jesús Del Mazo
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

6.  Markers of vitality in ovaries of transmen after long-term androgen treatment: a prospective cohort study.

Authors:  Julian Marschalek; Detlef Pietrowski; Sabine Dekan; Marie-Louise Marschalek; Maximilian Brandstetter; Johannes Ott
Journal:  Mol Med       Date:  2020-09-05       Impact factor: 6.354

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.